Nano-medicine inhibits progression of pancreatic cancer
Researchers have examined pancreatic cancer cells and discovered an inverse correlation between the signatures of miR-34a, a tumour suppressant, and PLK1, a known oncogene. The levels of miR-34a were low in pancreatic cancer mouse models, while the levels of the oncogene were high. This correlation made sense for such aggressive cancer. The research team now [...]









